Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
GoodRx Holdings (GDRX)
NASDAQ:GDRX
Holding GDRX?
Track your performance easily
GDRX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$4.09 - $9.26
Previous Close$4.24
Volume750.86K
Average Volume (3M)1.35M
Market Cap
$1.61B
Enterprise Value$1.74B
Total Cash (Recent Filing)$423.78M
Total Debt (Recent Filing)$544.57M
Price to Earnings (P/E)―
Beta1.07
Next Earnings
Feb 26, 2025EPS Estimate
$0.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding381,142,196
10 Day Avg. Volume3,103,243
30 Day Avg. Volume1,346,433
Standard Deviation0.19
R-Squared0.12
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)2.32
Price to Sales (P/S)2.00
Price to Cash Flow (P/CF)4.70
P/FCF Ratio5.70
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.20
Enterprise Value/Gross Profit2.54
Enterprise Value/Ebitda20.94
Forecast
1Y Price Target
$7.19Price Target Upside69.78% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
GoodRx Holdings News
Bulls Say, Bears Say
Bulls Say
Business Model And MarginsThe company's business model continues to shift towards higher margin lines of business, with the company consistently demonstrating an ability to improve margins and EBITDA growth.
E-commerce And Growth OpportunitiesGoodRx's introduction of an e-commerce solution is viewed positively and is believed to offer a real growth opportunity for the company over time.
Pharmacy Ecosystem IntegrationGDRX continues to further integrate itself into the pharmacy ecosystem, which deepens pharmacy/PBM/manufacturer relationships and insulates itself from the evolving reimbursement landscape.
Bears Say
Business Model VulnerabilityUntil GDRX shifts more of its model to higher dollar/sustainable revenue sources, it is susceptible to extraneous drivers.
Financial PerformanceThe company lowered revenue guidance for the 2nd straight quarter, a setback since the constructive Investor Day held earlier this year.
Retail Environment ChallengesOngoing store closures across the landscape and renegotiations of reimbursement rates are leading to choppiness in the core business.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
GDRX FAQ
What was GoodRx Holdings’s price range in the past 12 months?
GoodRx Holdings lowest stock price was $4.09 and its highest was $9.26 in the past 12 months.
What is GoodRx Holdings’s market cap?
Currently, no data Available
When is GoodRx Holdings’s upcoming earnings report date?
GoodRx Holdings’s upcoming earnings report date is Feb 26, 2025 which is in 98 days.
How were GoodRx Holdings’s earnings last quarter?
GoodRx Holdings released its earnings results on Nov 07, 2024. The company reported $0.08 earnings per share for the quarter, missing the consensus estimate of $0.087 by -$0.007.
Is GoodRx Holdings overvalued?
According to Wall Street analysts GoodRx Holdings’s price is currently Undervalued.
Does GoodRx Holdings pay dividends?
GoodRx Holdings does not currently pay dividends.
What is GoodRx Holdings’s EPS estimate?
GoodRx Holdings’s EPS estimate is $0.1.
How many shares outstanding does GoodRx Holdings have?
GoodRx Holdings has 104,272,870 shares outstanding.
What happened to GoodRx Holdings’s price movement after its last earnings report?
GoodRx Holdings reported an EPS of $0.08 in its last earnings report, missing expectations of $0.087. Following the earnings report the stock price went down -17.512%.
Which hedge fund is a major shareholder of GoodRx Holdings?
Among the largest hedge funds holding GoodRx Holdings’s share is Silver Lake Group, L.L.C.. It holds GoodRx Holdings’s shares valued at 25M.
---
GoodRx Holdings Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$7.19 (69.78% Upside)
$7.19 (69.78% Upside)
Blogger Sentiment
Neutral
GDRX Sentiment 58%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 13.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $83.9K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.0%
Last 30 Days ▼ 4.5%
Last 30 Days ▼ 4.5%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-18.92%
12-Months-Change
Fundamentals
Return on Equity
-2.06%
Trailing 12-Months
Asset Growth
-20.68%
Trailing 12-Months
Company Description
GoodRx Holdings
GoodRx Holdings Inc provides digital healthcare platform that provides prescription drugs at affordable prices. The company offers services like diabetes testing, general visits, blood tests, HIV testing, Vitamin D screening, Pregnancy testing, and many more.
---
GDRX Earnings Call
Q3 2024
0:00 / 0:00
---
GDRX Revenue Breakdown
73.41% Prescription transactions
12.58% Subscription
11.34% Pharma manufacturer solutions
2.67% Other
---
GDRX Stock 12 Month Forecast
Average Price Target
$7.19
▲(69.78% Upside)
Technical Analysis
Best Analysts Covering GDRX
1 Year
1 Year Success Rate
8/8 ratings generated profit
1 Year Average Return
+22.29%
assigned a sell rating 13 days ago
Copying Allen Lutz's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +22.29% per trade.
---